MiNK Therapeutics
INKT
INKT
34 hedge funds and large institutions have $800K invested in MiNK Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$24.5K | |
| 2 | +$2.27K | |
| 3 | +$463 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$440 |
| 5 |
Goldman Sachs
New York
|
+$330 |
Top Sellers
| 1 | -$682K | |
| 2 | -$236K | |
| 3 | -$107K | |
| 4 |
Renaissance Technologies
New York
|
-$95.9K |
| 5 |
VF
Virtu Financial
New York
|
-$30K |